Japan ticks Gropep mix
Thursday, 21 April, 2005
Adelaide biopharma GroPep has announced that a Japanese biopharmaceutical company has received regulatory approval in Japan to manufacture a biopharmaceutical product containing one of GroPep's products.
GroPep said commercial secrecy prevented it naming the ingredient, the company, or the product, but it is the sixth biopharmaceutical product containing GroPep's proprietary cell-culture products to receive regulatory approval.
It's not going to be a big source of revenue, but GroPep said the Japanese product is currently undergoing clinical trials for several other indications, some of which have multi-billion global markets.
CEO Bob Finder said the Japanese approval reinforced growing international recognition of the superiority of GroPep's cell culture products for the manufacture of certain biopharmaceutical products.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
